XORTX Therapeutics Inc. Increase Decrease Through Exercise Of Warrants Equity
XORTX Therapeutics Inc. (XRTX) reported Increase Decrease Through Exercise Of Warrants Equity of CAD 2.86 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-05-03.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2022-05-03
| Period end | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|
| 2021-12-31 | 2.86M CAD 20-F · filed 2022-05-03 |